Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Enriqueta Felip (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation
Dr. Enriqueta Felip, MD, PhD, is a renowned clinical oncologist based in Barcelona, Spain, with decades of experience in the diagnosis and treatment of thoracic cancers. She is affiliated with leading institutions such as Hospital Quirón Barcelona and Vall d’Hebron University Hospital.
- Over three decades of clinical and academic experience
- Specializes in thoracic oncology: lung cancer, mesothelioma, head and neck tumors
- Expert in targeted therapy, immunotherapy, and clinical trials
Educational Background
- Graduated from the Autonomous University of Barcelona (Spain), with an MD and PhD in Medicine
- Completed specialization in Medical Oncology at Vall d’Hebron University Hospital
- Associate Professor at the Autonomous University of Barcelona and later Professor at Universitat de Vic
- Recipient of several academic honors and awards for excellence in oncology education
Professional Experience
- Head of the Thoracic Tumors and Head & Neck Cancer Unit at Vall d’Hebron University Hospital
- Clinical oncologist at Hospital Quirón Barcelona
- Codirector of the Clinical Research Program at Vall d’Hebron Institute of Oncology (VHIO)
- Long-standing leadership in early-phase clinical trials and molecular oncology
Academic Contributions
- Professor of Medicine at the Autonomous University of Barcelona
- Regular lecturer at international congresses and oncology symposia
- Mentor and educator in thoracic oncology and molecular diagnostics
- Editor and reviewer for journals such as Annals of Oncology and Journal of Thoracic Oncology
Areas of Expertise
- Non-small cell lung cancer (NSCLC) – including personalized treatment with molecular testing
- Small cell lung cancer (SCLC) – advanced approaches including immunotherapy
- Head and neck tumors – integrating surgery, chemo- and radiotherapy
- Use of circulating tumor DNA (ctDNA) and liquid biopsy to monitor treatment progress
Publications and Research
Dr. Enriqueta Felip is the author of over 400 scientific publications in peer-reviewed medical journals. Her research focuses on innovative treatments in lung cancer, including immunotherapy and molecular-targeted drugs.
Selected publications:
- IMpower010 trial: Study on adjuvant atezolizumab in early-stage NSCLC
- Tarlatamab clinical trial: Evaluating novel treatments for relapsed small cell lung cancer
- ctDNA monitoring: Investigating the role of circulating tumor DNA in lung cancer management
Her academic profile is available on platforms such as PubMed, ORCID, and ResearchGate.
Patient Care Philosophy
- Believes in transparent, empathetic communication with patients
- Focuses on personalized treatment plans tailored to genetic and molecular profiles
- Advocates for international access to care through virtual consultations
- Known for creating strong doctor-patient relationships based on trust and collaboration
Professional Affiliations
- President of the Spanish Society of Medical Oncology (SEOM), former Vice-President
- Board member of the International Association for the Study of Lung Cancer (IASLC)
- Member of European Society for Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO)
- Active contributor to international guidelines and scientific boards
- Recipient of the ESMO Women for Oncology Award and other distinguished honors
FAQs
- Is Dr. Enriqueta Felip board-certified?
- Yes, she is board-certified in Medical Oncology in Spain and internationally recognized in her field.
- What types of cancers does she treat?
- She specializes in thoracic oncology, including lung cancer (NSCLC, SCLC), mesothelioma, and head and neck tumors.
- Does she treat international patients?
- Yes, she offers care to international patients and provides online consultations as part of Hospital Quirón Barcelona’s services.
- How long is the typical hospital stay for treatment?
- It varies by procedure, but the hospital offers both outpatient and inpatient treatment plans based on the patient’s condition.
- What languages does she speak?
- Dr. Felip speaks Spanish and English. Multilingual support is also available through the hospital.
- Is she involved in research or clinical trials?
- Yes, she leads numerous clinical trials and translational research programs in lung cancer and precision oncology.
- Can she provide a second opinion remotely?
- Yes, she is available for remote consultations and second opinions for patients worldwide.
Certification & Accreditation


